The emerging class of GLP-1 agonist medication and GIP dual medications, including tirzepatide, semaglutide, and the recently introduced retatrutide, provide promising progress in metabolic control. https://retatrutide380812.indoblognet.com/48113/semaglutide-one-thorough-look